Specialized Biotech Targeting NASH Shares Positive Results of Phase 1a/2b Study
NASH is a growing problem in American society—impacting over 16 million people with projected growth by 2030 as high as 63%. The disease is associated with…
Tag: Type 2 Diabetes
Lilly’s Weekly Insulin Shows Promise for Type 2 Diabetes Patients in Study Led by Los Angeles’ National Research Institute
Juan Frias, MD, a medical director with the National Research Institute based in Los Angeles, California will present at the Endocrine Society’s annual meeting known…
$5.6m for Large Retrospective Observational Study Targeting 600K Type 2 Diabetes Patients: The Move to Precision Treatments
$5.6 million was recently awarded to a team led by Kaiser Permanente Northern California Division of Research to study four classes of type 2 diabetes…
University of Alabama at Birmingham Observational Study: Metformin Use Leads to Three-Fold Reduction of COVID-19 Death in Patients with Type 2 Diabetes
In a National Institutes of Health (NIH) supported observational study, the University of Alabama at Birmingham (UAB) revealed that patients with Type 2 diabetes on…
University of Florida Secures $2.3m for First of its Kind in U.S. Investigating Fatty Liver in Type 2 Diabetics
The University of Florida won a $2.3 million grant in its quest to investigate liver scarring and inflammation triggered by fatty liver. The National institutes…
University of Tennessee Secures $1.98m to Pursue Possibly Breakthrough Protein Receptor to Address Type 2 Diabetes
University of Tennessee (UT) Health Science Center Memphis investigators secured $2 million to pursue their potentially breakthrough diabetes research. The Mid-South region in America has…
Clinical Research as a Care Option in Sacramento CA as Patient Turns Life Around
Clinical Trials Research, a clinical investigational site in the Sacramento, CA area recently saved the life of a man on the brink with diabetes. Like many…
Hebrew University’s Hadassah Medical Center Spin-off Developing Type 2 Diabetes Drug
Insulin resistance, the leading cause of Type 2 diabetes, is the target of a new drug under development in Israel. Developed at the Hebrew University-Hadassah…
WellCare Joins Forces with Fitbit to Help Manage Diabetes in Georgia’s Medicaid Population
WellCare of Georgia, a WellCare Health Plans, Inc. company (WCG), recently partnered with Fitbit to improve health and manage diabetes within the that state. WellCare is…
Type 2 Diabetic Crisis in India and Treatment Options: Caveat Emptor
With growth in India’s economy and middle class has come new diseases heretofore not that pervasive in India, such as diabetes. India has the most diabetics…